hackettg

/hackettg

About hackettg

This author has not yet filled in any details.
So far hackettg has created 133 blog entries.

MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd)

MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/18 Date issued: 24 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Brilique 90mg tablets (G Pharma Ltd) as G Pharma Ltd have informed the MHRA that there is [...]

The post MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) appeared first on Community Pharmacy England.

By |April 24th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd)

April 2025 Drug Tariff updates

The NHS Business Services Authority (NHSBSA) has published updates to the April Drug Tariff to include details from the CPCF arrangements for 2025/26. These updates can be found on the NHSBSA website here and include the following: Part I – Changes to the Payment Timetable to include earlier fee payments for the Hypertension Case Finding Service [...]

The post April 2025 Drug Tariff updates appeared first on Community Pharmacy England.

By |April 2nd, 2025|Lexpos News|Comments Off on April 2025 Drug Tariff updates

Drug Tariff Watch – April 2025

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2025. From 1st April, the Single Activity Fee (SAF) will increase by 19p to £1.46 per item. For more information see CPCF arrangements for 2024/25 and [...]

The post Drug Tariff Watch – April 2025 appeared first on Community Pharmacy England.

By |March 31st, 2025|Lexpos News|Comments Off on Drug Tariff Watch – April 2025

National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials

National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials National Patient Safety Alert Reference Number: NatPSA/2025/001/DHSC Date issued: 17 March 2025 Explanation of identified safety issue Promixin® (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) are being discontinued from early May 2025, with stocks anticipated [...]

The post National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials appeared first on Community Pharmacy England.

By |March 17th, 2025|Lexpos News|Comments Off on National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials

Drug Tariff Watch – March 2025

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – March 2025 appeared first on Community Pharmacy England.

By |February 26th, 2025|Lexpos News|Comments Off on Drug Tariff Watch – March 2025